foxo4-dri senolytic human trial peptide 2024 Class II senolytics inhibit survival pathways elicited by senescent FOXO4-DRI alleviates age-related testosterone secretion
Pay in 4 interest-free payments of $5.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
























